Achieve Life Sciences, Inc.
ACHV
$4.62
-$0.16-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 25.92M | 21.40M | 18.87M | 16.25M | 13.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.34M | 50.11M | 45.98M | 39.07M | 31.27M |
| Operating Income | -52.34M | -50.11M | -45.98M | -39.07M | -31.27M |
| Income Before Tax | -52.35M | -50.42M | -46.16M | -39.83M | -32.94M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -52.35 | -50.42 | -46.16 | -39.83 | -32.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.35M | -50.42M | -46.16M | -39.83M | -32.94M |
| EBIT | -52.34M | -50.11M | -45.98M | -39.07M | -31.27M |
| EBITDA | -52.11M | -49.88M | -45.75M | -38.84M | -31.04M |
| EPS Basic | -1.38 | -1.46 | -1.34 | -1.23 | -1.13 |
| Normalized Basic EPS | -0.85 | -0.89 | -0.82 | -0.75 | -0.68 |
| EPS Diluted | -1.38 | -1.46 | -1.34 | -1.23 | -1.13 |
| Normalized Diluted EPS | -0.85 | -0.89 | -0.82 | -0.75 | -0.68 |
| Average Basic Shares Outstanding | 154.90M | 138.24M | 137.87M | 128.23M | 114.89M |
| Average Diluted Shares Outstanding | 154.90M | 138.24M | 137.87M | 128.23M | 114.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |